Trial Profile
Post-Marketing Surveillance Study of Aripiprazole in Patients With Autism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2021
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 08 Jun 2021 Status changed from recruiting to completed.
- 04 Sep 2020 Planned End Date changed from 1 Dec 2019 to 1 Sep 2020.
- 28 Aug 2019 Planned End Date changed from 1 Sep 2019 to 1 Dec 2019.